Related Experiment Video
Updated: Aug 5, 2026
03:19
Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Maternal Smoking and Preterm Birth Among Infants With Orofacial Clefts
Peichun Han1, Renata H Benjamin1, Katherine L Ludorf1
1Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Summary
Maternal heavy smoking during pregnancy, especially in the second trimester, is linked to preterm birth (PTB) in infants with orofacial clefts (OFCs). This highlights the need for smoking cessation programs for expectant mothers to reduce PTB risks.
Area of Science:
- Reproductive Health
- Pediatric Health
- Birth Defect Research
Background:
- Orofacial clefts (OFCs) are common birth defects.
- Maternal smoking is a known risk factor for adverse pregnancy outcomes.
- The specific impact of smoking on preterm birth (PTB) in infants with OFCs requires further investigation.
Purpose of the Study:
- To assess the association between maternal cigarette smoking and PTB in infants diagnosed with OFCs.
- To examine smoking's impact across different OFC types (cleft lip with/without cleft palate, cleft palate only) and pregnancy timepoints.
Main Methods:
- A population-based retrospective cohort study utilizing data from the National Birth Defects Prevention Study and the Birth Defects Study To Evaluate Pregnancy exposures.
- Analysis included 5618 liveborn infants with OFCs.
- Poisson regression was used to calculate adjusted relative risks (aRRs) for PTB (<37 weeks) associated with maternal smoking (any vs. none, and intensity) at various pregnancy stages.
Main Results:
- 14.5% of infants with OFCs experienced preterm birth.
- Heavy maternal smoking (≥15 cigarettes/day) in the second trimester was significantly associated with PTB in infants with cleft palate only (aRR: 1.89) and extremely-to-very PTB (<32 weeks) in infants with any OFC (aRR: 3.37).
- Associations were generally stronger for cleft palate only compared to cleft lip with/without cleft palate.
Conclusions:
- Heavy maternal smoking during the second trimester may elevate the risk of severe preterm birth in infants with OFCs.
- The findings underscore the critical importance of maternal smoking cessation or reduction during pregnancy to mitigate PTB risks in this vulnerable population.
- Further research may refine understanding of smoking intensity and timing effects on specific OFC subtypes and PTB.
Related Concept Videos
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...